Historical shareholding details of
Citadel Advisors Llc
holdings in Acrivon Therapeutics Inc (ACRV)
Monthly changes of
Citadel Advisors Llc
shareholding in Acrivon Therapeutics Inc
over the previous
months
|
Month
|
Name |
Total no. shares held |
Percent Holding |
|
Mar 31, 2025
|
Citadel Advisors Llc
|
1,895,519
|
6.03%
|
|
|
|
Dec 31, 2024
|
Citadel Advisors Llc
|
2,119,646
|
6.76%
|
|
|
|
Sep 30, 2024
|
Citadel Advisors Llc
|
2,140,628
|
6.88%
|
|
|
|
Jun 30, 2024
|
Citadel Advisors Llc
|
2,119,646
|
6.84%
|
|
|
|
Sep 30, 2023
|
Citadel Advisors Llc
|
1,650,457
|
7.44%
|
|
|
|
Jun 30, 2023
|
Citadel Advisors Llc
|
1,649,646
|
7.47%
|
|
|
|
Mar 31, 2023
|
Citadel Advisors Llc
|
1,641,022
|
7.48%
|
View all ownership details of Acrivon Therapeutics Inc